Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells.

Malavaki CJ, Roussidis AE, Gialeli C, Kletsas D, Tsegenidis T, Theocharis AD, Tzanakakis GN, Karamanos NK.

FEBS J. 2013 May;280(10):2477-89. doi: 10.1111/febs.12163. Epub 2013 Feb 27.

2.

Small tyrosine kinase inhibitors as key molecules in the expression of metalloproteinases by solid tumors.

Stahtea XN, Kousidou OCh, Roussidis AE, Tzanakakis GN, Karamanos NK.

Connect Tissue Res. 2008;49(3):211-4. doi: 10.1080/03008200802143307. Review.

PMID:
18661345
3.

Imatinib mesylate inhibits proliferation and exerts an antifibrotic effect in human breast stroma fibroblasts.

Gioni V, Karampinas T, Voutsinas G, Roussidis AE, Papadopoulos S, Karamanos NK, Kletsas D.

Mol Cancer Res. 2008 May;6(5):706-14. doi: 10.1158/1541-7786.MCR-07-0355.

4.

Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation.

Stahtea XN, Roussidis AE, Kanakis I, Tzanakakis GN, Chalkiadakis G, Mavroudis D, Kletsas D, Karamanos NK.

Int J Cancer. 2007 Dec 15;121(12):2808-14.

5.

The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer.

Roussidis AE, Theocharis AD, Tzanakakis GN, Karamanos NK.

Curr Med Chem. 2007;14(7):735-43. Review.

PMID:
17346159
6.

Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors.

Kousidou OC, Mitropoulou TN, Roussidis AE, Kletsas D, Theocharis AD, Karamanos NK.

Int J Oncol. 2005 Apr;26(4):1101-9.

PMID:
15754008
7.
8.

STI571 as a potent inhibitor of growth and invasiveness of human epithelial breast cancer cells.

Roussidis AE, Mitropoulou TN, Theocharis AD, Kiamouris C, Papadopoulos S, Kletsas D, Karamanos NK.

Anticancer Res. 2004 May-Jun;24(3a):1445-7.

9.

A rapid method for fractionation and purification of a 92 kDa cartilage glycoprotein.

Roussidis AE, Anagnostides ST.

Biomed Chromatogr. 2004 Apr;18(3):139-42.

PMID:
15103697
10.

Inhibition of receptor tyrosine kinase-based signal transduction as specific target for cancer treatment.

Roussidis AE, Karamanos NK.

In Vivo. 2002 Nov-Dec;16(6):459-69. Review.

PMID:
12494890

Supplemental Content

Loading ...
Support Center